IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.134
AS - Asia 8.314
EU - Europa 7.343
SA - Sud America 1.505
Continente sconosciuto - Info sul continente non disponibili 838
AF - Africa 195
OC - Oceania 24
Totale 34.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.876
CN - Cina 3.038
SG - Singapore 2.712
UA - Ucraina 1.800
BR - Brasile 1.267
IT - Italia 1.007
PL - Polonia 962
DE - Germania 863
HK - Hong Kong 845
FR - Francia 687
FI - Finlandia 577
VN - Vietnam 495
GB - Regno Unito 486
IN - India 370
TR - Turchia 311
IE - Irlanda 296
RU - Federazione Russa 289
BD - Bangladesh 153
CA - Canada 139
AR - Argentina 80
SE - Svezia 76
IQ - Iraq 67
MX - Messico 63
CZ - Repubblica Ceca 55
BE - Belgio 53
ZA - Sudafrica 53
ID - Indonesia 48
EC - Ecuador 45
JP - Giappone 40
IR - Iran 36
NL - Olanda 35
ES - Italia 32
PK - Pakistan 30
KR - Corea 29
NG - Nigeria 27
VE - Venezuela 26
AT - Austria 23
CH - Svizzera 21
KE - Kenya 21
AU - Australia 20
CO - Colombia 19
UZ - Uzbekistan 19
CL - Cile 18
EG - Egitto 18
MA - Marocco 17
PY - Paraguay 16
SA - Arabia Saudita 16
EU - Europa 15
JO - Giordania 14
MU - Mauritius 14
TN - Tunisia 13
PE - Perù 12
UY - Uruguay 12
CR - Costa Rica 10
ET - Etiopia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
BG - Bulgaria 8
BO - Bolivia 8
DZ - Algeria 8
RO - Romania 8
AZ - Azerbaigian 7
KG - Kirghizistan 7
BA - Bosnia-Erzegovina 6
GR - Grecia 6
GT - Guatemala 6
NP - Nepal 6
PA - Panama 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
AL - Albania 5
DO - Repubblica Dominicana 5
HN - Honduras 5
HR - Croazia 5
JM - Giamaica 5
MD - Moldavia 5
OM - Oman 5
AM - Armenia 4
CY - Cipro 4
DK - Danimarca 4
HU - Ungheria 4
MY - Malesia 4
RS - Serbia 4
BB - Barbados 3
EE - Estonia 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
LV - Lettonia 3
NI - Nicaragua 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
BH - Bahrain 2
BY - Bielorussia 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 33.498
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Singapore 1.453
Jacksonville 1.290
Ashburn 1.241
Warsaw 954
Houston 921
Hong Kong 842
Ann Arbor 790
Cambridge 681
Seattle 584
Chandler 579
Wilmington 573
San Jose 553
Beijing 535
The Dalles 533
Princeton 527
Nanjing 466
New York 347
Brescia 333
Dublin 295
Helsinki 290
Dearborn 279
Columbus 254
Los Angeles 250
Lauterbourg 249
Istanbul 239
Nanchang 182
Ho Chi Minh City 159
Shenyang 148
Council Bluffs 144
Munich 141
Des Moines 131
Hebei 131
Milan 126
Buffalo 116
Moscow 116
Dallas 110
Tianjin 106
Hanoi 104
Jinan 98
São Paulo 98
Shanghai 94
Changsha 92
San Francisco 83
San Diego 79
Santa Clara 75
Pune 73
Jiaxing 69
Lancaster 66
Orem 66
Toronto 62
London 61
Redondo Beach 61
Chicago 58
Kunming 51
San Mateo 48
Brussels 47
Turku 47
Hangzhou 46
Verona 45
Dong Ket 42
Ningbo 41
Rio de Janeiro 39
Brno 38
Brooklyn 37
Denver 37
Rome 37
Kocaeli 36
Augusta 35
Guangzhou 35
Phoenix 35
Tokyo 35
Frankfurt am Main 33
Ardabil 32
Leawood 32
Zhengzhou 32
Montreal 31
San Donà Di Piave 31
Boardman 30
Brasília 28
Haikou 28
Johannesburg 28
Monmouth Junction 27
Poplar 27
Taizhou 27
Abuja 26
Norwalk 24
Atlanta 23
Manchester 23
Mexico City 23
Romola 23
Mumbai 22
Lanzhou 21
Belo Horizonte 20
Chennai 19
Nairobi 19
Haiphong 18
Ankara 17
Baghdad 17
Totale 22.374
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 322
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 306
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 298
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 280
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 266
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 263
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 249
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 248
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 228
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 227
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 225
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 195
The D3 dopamine receptor: From structural interactions to function. 193
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 193
Palbociclib inhibits proliferation of human adrenocortical tumor cells 190
A new pharmacological approach to the facilitation of acetylcholine transmission. 184
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 184
Age-related changes of enkephalin in rat spinal cord 180
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 179
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 178
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 177
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 177
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 175
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 175
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 175
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 173
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 172
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 170
A superfusion method for the study of calcium fluxes from pituitary cells. 169
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 168
Synapsin III alterations in Parkinson's disease 168
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 165
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 165
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 165
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 165
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 164
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 163
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 163
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 162
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 162
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 161
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 161
Stimulation of dopamine D-2 receptors increases potassium permeability in mammotrophs. 157
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 155
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 154
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 154
Caveolins in rhabdomyosarcoma 153
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 150
Ormoni Anteroipofisari 150
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 150
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 149
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 147
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 147
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 146
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 145
Synapsin III Alteration in Parkinson's disease 145
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 144
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 144
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 143
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 143
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 143
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 142
Pharmacological basis for dopamine D-2 receptor diversity 142
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 142
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 141
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 141
The NMDA/D1 receptor complex as a new target in drug development 140
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 139
Different neurotransmitter systems are involved in the development of esophageal achalasia 139
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 139
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 139
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 139
Synapsin III Alteration in Parkinson's disease 138
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 137
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 136
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 135
Dopamine receptors are present in rat and human esophagus 135
Nerve growth factor signaling in prostate health and disease. 135
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 134
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 134
Afferent fibers mediate the increse of met-enkephalin elicited in rat spinal cord by localized pain. 134
[Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. 134
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 134
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 134
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 133
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 133
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 133
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 133
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 133
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 133
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 132
Sex-related variations in serum nerve growth factor concentration in humans. 132
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 132
Dopamine D3 receptor heteromerization: Implications for neuroplasticity and neuroprotection 132
Dopamine receptors and brain function 131
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 131
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 131
Totale 16.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.961 0 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20254.242 23 46 58 545 471 346 407 105 511 286 877 567
2025/20268.233 753 1.112 658 1.335 755 558 1.229 322 495 686 218 112
2026/2027629 432 197 0 0 0 0 0 0 0 0 0 0
Totale 34.353